Article
Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.
Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Top 5 Articles of the Week: February 2-7
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Topical Corticosteroids: Potency, Vehicles, and Best Practices